Trial Profile
Regulatory Post Marketing Surveillance Study of NovoRapid for New Drug Re-examination.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2016
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 17 Dec 2011 New trial record